vs
Side-by-side financial comparison of Chatham Lodging Trust (CLDT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $67.7M, roughly 1.1× Chatham Lodging Trust). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -9.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.5%).
Chatham Lodging Trust is a publicly traded real estate investment trust that invests in, owns, and operates upscale extended-stay and select-service premium hotel properties primarily across high-demand urban and suburban markets in the United States. Its portfolio targets assets with strong occupancy rates and steady cash flow from business and leisure traveler segments.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CLDT vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $67.7M | $75.5M |
| Net Profit | $4.6M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 15.9% | 22.7% |
| Net Margin | 6.8% | — |
| Revenue YoY | -9.8% | 27.7% |
| Net Profit YoY | 369.9% | — |
| EPS (diluted) | $0.05 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $67.7M | $75.5M | ||
| Q3 25 | $78.4M | $54.5M | ||
| Q2 25 | $80.3M | $52.4M | ||
| Q1 25 | $68.6M | $46.0M | ||
| Q4 24 | $75.1M | $59.1M | ||
| Q3 24 | $87.2M | $80.5M | ||
| Q2 24 | $86.5M | $47.1M | ||
| Q1 24 | $68.4M | $43.8M |
| Q4 25 | $4.6M | — | ||
| Q3 25 | $3.5M | $8.8M | ||
| Q2 25 | $5.4M | $5.9M | ||
| Q1 25 | $1.5M | $3.0M | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $4.3M | $20.3M | ||
| Q2 24 | $6.8M | $-4.5M | ||
| Q1 24 | $-5.2M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | 40.7% | 76.4% | ||
| Q3 24 | 44.7% | 63.9% | ||
| Q2 24 | 46.1% | 77.4% | ||
| Q1 24 | 38.9% | 75.5% |
| Q4 25 | 15.9% | 22.7% | ||
| Q3 25 | 12.7% | 17.6% | ||
| Q2 25 | 14.8% | 12.7% | ||
| Q1 25 | 12.1% | 8.7% | ||
| Q4 24 | 7.5% | 22.6% | ||
| Q3 24 | 14.3% | 27.4% | ||
| Q2 24 | 16.3% | -4.6% | ||
| Q1 24 | 1.4% | -5.3% |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 4.5% | 16.2% | ||
| Q2 25 | 6.7% | 11.2% | ||
| Q1 25 | 2.2% | 6.5% | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 4.9% | 25.2% | ||
| Q2 24 | 7.9% | -9.6% | ||
| Q1 24 | -7.6% | -11.0% |
| Q4 25 | $0.05 | $0.26 | ||
| Q3 25 | $0.03 | $0.17 | ||
| Q2 25 | $0.07 | $0.12 | ||
| Q1 25 | $-0.01 | $0.06 | ||
| Q4 24 | $-0.08 | $0.40 | ||
| Q3 24 | $0.05 | $0.41 | ||
| Q2 24 | $0.10 | $-0.09 | ||
| Q1 24 | $-0.15 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.4M | $97.5M |
| Total DebtLower is stronger | $338.9M | $22.7M |
| Stockholders' EquityBook value | $740.8M | $130.3M |
| Total Assets | $1.2B | $216.3M |
| Debt / EquityLower = less leverage | 0.46× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.4M | $97.5M | ||
| Q3 25 | $13.2M | $94.4M | ||
| Q2 25 | $17.2M | $96.0M | ||
| Q1 25 | $18.6M | $93.2M | ||
| Q4 24 | $20.2M | $101.0M | ||
| Q3 24 | $19.3M | $96.7M | ||
| Q2 24 | $10.6M | $96.8M | ||
| Q1 24 | $72.3M | $107.2M |
| Q4 25 | $338.9M | $22.7M | ||
| Q3 25 | $338.8M | $34.0M | ||
| Q2 25 | $351.2M | $45.3M | ||
| Q1 25 | $381.1M | $56.7M | ||
| Q4 24 | $406.9M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $740.8M | $130.3M | ||
| Q3 25 | $749.4M | $115.3M | ||
| Q2 25 | $754.1M | $104.7M | ||
| Q1 25 | $754.7M | $97.1M | ||
| Q4 24 | $758.2M | $92.1M | ||
| Q3 24 | $765.3M | $71.1M | ||
| Q2 24 | $766.5M | $48.5M | ||
| Q1 24 | $765.0M | $51.0M |
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.2B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.3B | $220.7M | ||
| Q2 24 | $1.3B | $205.0M | ||
| Q1 24 | $1.3B | $214.1M |
| Q4 25 | 0.46× | 0.17× | ||
| Q3 25 | 0.45× | 0.30× | ||
| Q2 25 | 0.47× | 0.43× | ||
| Q1 25 | 0.50× | 0.58× | ||
| Q4 24 | 0.54× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.1M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 13.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.1M | $14.4M | ||
| Q3 25 | $25.6M | $9.7M | ||
| Q2 25 | $22.1M | $14.1M | ||
| Q1 25 | $4.2M | $3.6M | ||
| Q4 24 | $73.8M | $15.6M | ||
| Q3 24 | $28.8M | $11.0M | ||
| Q2 24 | $25.2M | $1.0M | ||
| Q1 24 | $6.9M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 13.90× | — | ||
| Q3 25 | 7.24× | 1.10× | ||
| Q2 25 | 4.10× | 2.41× | ||
| Q1 25 | 2.73× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.78× | 0.54× | ||
| Q2 24 | 3.68× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLDT
| Occupancy | $61.5M | 91% |
| Hotel Other | $4.2M | 6% |
| Food And Beverage | $1.8M | 3% |
| Hotel | $1.1M | 2% |
PBYI
Segment breakdown not available.
